BridgeBio Pharma, Inc. Annual Costs and Expenses in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BridgeBio Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2023.
  • BridgeBio Pharma, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $194M, a 20.2% increase year-over-year.
  • BridgeBio Pharma, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $762M, a 34% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2023 was $617M, a 4.55% increase from 2022.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2022 was $590M, a 8.74% decline from 2021.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2021 was $646M, a 33.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $617M +$26.8M +4.55% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $590M -$56.5M -8.74% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $646M +$164M +33.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $483M +$176M +57.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $307M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.